ASD holdings
All 39 positions of Defiance Autism Impact ETF.
Positions
39
Top 10 weight
30.8%
Effective holdings
37.1
1 / sum of squared weights
In stocks
99.8%
In bonds
0.0%
Outside the US
43.5%
Asset mix
Sectors
59% of stocks classifiedCountries
Holdings
| # | Holding | Type | Weight | Value | Shares / par | Country |
|---|---|---|---|---|---|---|
| 1 | DFTXDefinium Therapeutics, Inc. Common Shares | Equity | 4.77% | $64K | 1,370 | US |
| 2 | Neuren Pharmaceuticals Ltd | Equity | 3.23% | $44K | 3,554 | AU |
| 3 | LFSTLifeStance Health Group, Inc. Common Stock | Equity | 3.04% | $41K | 3,838 | US |
| 4 | Otsuka Holdings Co Ltd | Equity | 2.95% | $40K | 600 | JP |
| 5 | ACHCAcadia Healthcare Company, Inc. | Equity | 2.90% | $39K | 1,328 | US |
| 6 | ACADAcadia Pharmaceuticals Inc. | Equity | 2.89% | $39K | 1,544 | US |
| 7 | MPLTMapLight Therapeutics, Inc. Common Stock | Equity | 2.89% | $39K | 1,088 | US |
| 8 | ABBVABBVIE INC. | Equity | 2.72% | $37K | 146 | US |
| 9 | BTSGBrightSpring Health Services, Inc. Common Stock | Equity | 2.70% | $37K | 524 | US |
| 10 | RVTYRevvity, Inc. | Equity | 2.68% | $36K | 326 | US |
| 11 | BFAMBRIGHT HORIZONS FAMILY SOLUTIONS INC. | Equity | 2.65% | $36K | 506 | US |
| 12 | Medicover AB | Equity | 2.63% | $36K | 1,496 | SE |
| 13 | Ipsen SA | Equity | 2.60% | $35K | 182 | FR |
| 14 | Sumitomo Pharma Co Ltd | Equity | 2.60% | $35K | 3,800 | JP |
| 15 | JNJJohnson & Johnson | Equity | 2.59% | $35K | 138 | US |
| 16 | BWAYBrainsway Ltd. American Depositary Shares | Equity | 2.58% | $35K | 2,250 | IL |
| 17 | Pearson PLC | Equity | 2.56% | $35K | 2,182 | GB |
| 18 | AVXLAnavex Life Sciences | Equity | 2.53% | $34K | 13,216 | US |
| 19 | Novartis AG | Equity | 2.53% | $34K | 218 | CH |
| 20 | Life Healthcare Group Holdings | Equity | 2.52% | $34K | 53,486 | ZA |
| 21 | BMRNBioMarin Pharmaceuticals Inc | Equity | 2.52% | $34K | 594 | US |
| 22 | KPJ Healthcare Bhd | Equity | 2.51% | $34K | 42,600 | MY |
| 23 | RGENRepligen Corp | Equity | 2.50% | $34K | 248 | US |
| 24 | Roche Holding AG | Equity | 2.50% | $34K | 82 | CH |
| 25 | SUPNSupernus Pharmaceuticals, Inc. | Equity | 2.50% | $34K | 726 | US |
| 26 | Jazz Pharmaceuticals PLC | Equity | 2.50% | $34K | 140 | IE |
| 27 | LLYEli Lilly & Co. | Equity | 2.49% | $34K | 28 | US |
| 28 | BMYBristol-Myers Squibb Co. | Equity | 2.47% | $33K | 580 | US |
| 29 | GSK PLC | Equity | 2.46% | $33K | 1,264 | GB |
| 30 | VNDAVanda Pharmaceuticals Inc. | Equity | 2.45% | $33K | 5,416 | US |
| 31 | GHCGRAHAM HOLDINGS COMPANY | Equity | 2.37% | $32K | 28 | US |
| 32 | Teva Pharmaceutical Industries | Equity | 2.35% | $32K | 962 | IL |
| 33 | Takeda Pharmaceutical Co Ltd | Equity | 2.35% | $32K | 1,000 | JP |
| 34 | LOPEGrand Canyon Education, Inc | Equity | 2.31% | $31K | 218 | US |
| 35 | H Lundbeck A/S | Equity | 2.29% | $31K | 4,768 | DK |
| 36 | Shionogi & Co Ltd | Equity | 2.29% | $31K | 1,800 | JP |
| 37 | PFEPfizer Inc. | Equity | 2.25% | $30K | 1,262 | US |
| 38 | LRNStride, Inc. | Equity | 2.12% | $29K | 332 | US |
| 39 | First American Government Obli | Cash | 0.21% | $3K | 2,894 | US |
Find which other funds hold a stock by opening it and choosing "ETFs holding".
Fund data comes from each fund's SEC filings and issuer disclosures and is shown with the date it is as of. SEC portfolio and flow filings become public about 60 days after the period they cover. Nothing here is investment advice; see Terms.